News

Fujifilm and National Center of Neurology and Psychiatry announce positive study results of Fujifilm’s AI technology predicting mild cognitive impairment conversion to Alzheimer’s disease

Fujifilm to terminate the enrollment of subjects in the phase III clinical trial of anti-influenza drug Avigan^® Tablet in Japan, targeting COVID-19 patients

BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases

Fujifilm announces the Start of a New Phase III Clinical Trial of Anti-influenza Drug Avigan^® Tablet in Japan, Targeting COVID-19 Patients

Fujifilm applies for manufacturing and marketing approval for a SARS-CoV-2antigen test kit using silver amplification immunochromatography method

Fujifilm Partners with Chinese Pharmaceutical Company Carelink in Deploying Anti-influenza Drug Avigan^® Tablets in China

Fujifilm Filed an Application for Partial Changes to the Manufacturing and Marketing Approval Matters of Anti-Influenza Drug Avigan^® Tablet in Japan to Include Additional Indication for COVID-19

Fujifilm Starts a Clinical Investigation in Europe on FF-37101, a Bone Grafting Material Useful for Bone Regeneration

A new magnetic recording method using millimeter/terahertz waves !!

Fujifilm to develop a highly-sensitive and rapid antigen test kit for SARS-CoV-2 utilizing silver halide amplification technology

Anti-influenza drug Avigan^® Tablet
Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients

To realize a new therapeutic option for neuroendocrine tumors
Domestic marketing approval application filed for new radiopharmaceutical F-1515 (FUJIFILM Toyama Chemical)

Centus Biotherapeutics Announces Positive CHMP Opinion for FKB238, Biosimilar Bevacizumab

Fujifilm partners with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan

Fujifilm collaborates with Merck & Co., Inc., Kenilworth, N.J., U.S.A.  in a clinical trial for advanced solid tumor in combination therapy of FF-10832, a liposome drug candidate with KEYTRUDA^® (pembrolizumab)

Fujifilm to develop AI-based technology to aid COVID-19-induced pneumonia diagnosis and assess the effectiveness of treatments

FUJIFILM Toyama Chemical starts a Phase I Clinical Trial of
FF-21101 for the Treatment of Advanced Solid Tumors in Japan (FUJIFILM Toyama Chemical Co., Ltd.)

Fujifilm accelerates production of its influenza antiviral drug “Avigan^® Tablet” for COVID-19

Fujifilm announces the start of a phase II clinical trial of its influenza antiviral drug “Avigan^® Tablet” for COVID-19 patients in the U.S.  

Fujifilm announces the start of a phase III clinical trial of influenza antiviral drug “Avigan Tablet” on COVID-19 and commits to increasing production